Psoriasis trials in Austria

3 of 3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  Where

  Graz, Stockerau, Vienna

  Age

  18 years to 75 years

  People

  1,200 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06764693
• No phaseTaking people
  A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

  Where

  Graz

  Age

  18 years to 99 years

  People

  110

  Run by

  Almirall, S.A.

  See details and how to joinNCT06029257
• No phaseTaking people
  A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

  Where

  Graz

  Age

  18 years and over

  People

  50

  Run by

  Almirall, S.A.

  See details and how to joinNCT06030076